Joshua Brody, MD
img_Joshua Brody
ASSOCIATE PROFESSOR | Medicine, Hematology and Medical Oncology
ASSOCIATE PROFESSOR | Oncological Sciences
ASSOCIATE PROFESSOR | Immunology & Immunotherapy
Are you a patient?
Specialties
Internal Medicine, Cancer (Oncology)
Multi-Disciplinary Training Area
Cancer Biology [CAB], Immunology [IMM]

BA, Harvard University

MD, State University of NY at Stony Brook School of Medicine

MD, State University of New York Stony Brook School of Medicine

Residency, Internal Medicine, Yale New Haven Hospital

Fellowship, Medical Oncology, Stanford University School of Medicine

Certifications

American Board of Internal Medicine

2011

Society for Immunotherapy of Cancer Presidential Award (SITC 26th Annual Meeting)

2011

SCL Award for top abstract submitted to 2011 International Conference on Malignant Lymphoma

Swiss Cancer League

2011

ASCO Merit Award for top 100 abstracts submitted to 2011 Annual Meeting

American Society of Clinical Oncology

2009

Howard Temin Pathway to Independence Award in Cancer Research (K99/R00) – [1 K99 CA140728-01] ”Immunotransplant to Treat Lymphoma” – 09/09 – 08/14

NCI

2009

‘Outstanding Recent Graduate’

SUNY Stony Brook School of Medicine

2008

ASCO Bradley Stuart Beller Foundation Fellowship Merit Award for best abstract submitted to 2008 Annual Meeting

American Society of Clinical Oncology

2008

William Guy Forbeck Scholar Award – invited to present at 2008 Forum

William Guy Forbeck Research Foundation

2008

MCLC featured researcher

Mantle Cell Lymphoma Consortium

Publications

Selected Publications

Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial. Joshua D. Brody, Judit Jørgensen, David Belada, Régis Costello, Marek Trněný, Umberto Vitolo, David John Lewis, Yasmin H. Karimi, Anna Sureda, Marc André, Björn E. Wahlin, Pieternella J. Lugtenburg, Tony Jiang, Kubra Karagoz, Andrew J. Steele, Aqeel Abbas, Liwei Wang, Malene Risum, Raul Cordoba. Blood

Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed/refractory large B-cell lymphoma. Lorenzo Falchi, Martin Hutchings, Carmelo Carlo-Stella, Franck Morschhauser, Michael Dickinson, Guillaume Cartron, Cyrus Khan, Monica Tani, Joaquin Martinez-Lopez, Nancy L. Bartlett, Antonio Salar, Joshua D. Brody, Sirpa Leppä, Aurelien Berthier, Martine Kallemeijn, James Relf, Fabiola Bene Tchaleu, Linda Lundberg, Emmanuel Bachy. Haematologica

Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translation. Zachary S. Morris, Sandra Demaria, Arta M. Monjazeb, Silvia C. Formenti, Ralph R. Weichselbaum, James Welsh, Heiko Enderling, Jonathan D. Schoenfeld, Joshua D. Brody, Heather M. McGee, Michele Mondini, Michael S. Kent, Kristina H. Young, Lorenzo Galluzzi, Sana D. Karam, Willemijn S.M.E. Theelen, Joe Y. Chang, Mai Anh Huynh, Adi Daib, Sean Pitroda, Caroline Chung, Raphael Serre, Clemens Grassberger, Jie Deng, Quaovi H. Sodji, Anthony T. Nguyen, Ravi B. Patel, Simone Krebs, Anusha Kalbasi, Caroline Kerr, Claire Vanpouille-Box, Logan Vick, Todd A. Aguilera, Irene M. Ong, Fernanda Herrera, Hari Menon, Dee Dee Smart, Jalal Ahmed, Robyn D. Gartrell, Christina L. Roland, Fatemeh Fekrmandi, Binita Chakraborty, Eric H. Bent, Tracy J. Berg, Alan Hutson, Samir Khleif, Andrew G. Sikora, Lawrence Fong. The Lancet Oncology

View All Publications

Joshua Brody, MD

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Brody has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.